Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycohip Plus
- Development stage
- Unknown
- Lead developer
- Allgems Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Glycohip Plus is an oral dietary supplement developed by Allgems Healthcare, specifically formulated for joint health and the management of joint disorders such as osteoarthritis. It is a combination product that typically contains rosehip extract, glucosamine, and often collagen peptides. Rosehip extract (derived from *Rosa canina*) contains galactolipids that exhibit anti-inflammatory properties by inhibiting the chemotaxis of polymorphonuclear leukocytes and reducing levels of C-reactive protein. Glucosamine serves as a fundamental building block for the synthesis of glycosaminoglycans and proteoglycans, which are essential components of the cartilage matrix. Together, these ingredients aim to reduce joint pain, improve mobility, and support the structural integrity of joint cartilage. The product is marketed as a branded generic/nutraceutical in the Indian market.
- Brand names
- Glycohip Plus
Beyond the preview
Go deeper on Glycohip Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycohip Plus.